Retraction Note to: Comparison of hepatocellular carcinoma (HCC), cholangiocarcinoma (CC), and combined HCC-CC (CHC) with each other based on microarray dataset

The Publisher and Editor retract this article in accordance with the recommendations of the Committee on Publication Ethics (COPE). After a thorough investigation we have strong reason to believe that the peer review process was compromised.

[1]  Hui Gao,et al.  Bicluster and pathway enrichment analysis of HCV-induced cirrhosis and hepatocellular carcinoma. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[2]  Mary Ann Comunale,et al.  Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma. , 2006, Journal of proteome research.

[3]  Gary D. Bader,et al.  An automated method for finding molecular complexes in large protein interaction networks , 2003, BMC Bioinformatics.

[4]  Christie S. Chang,et al.  The BioGRID interaction database: 2013 update , 2012, Nucleic Acids Res..

[5]  Walter Heindel,et al.  Infarction of tumor vessels by NGR-peptide-directed targeting of tissue factor: experimental results and first-in-man experience. , 2009, Blood.

[6]  K. Chayama,et al.  Impact of radiation and hepatitis virus infection on risk of hepatocellular carcinoma , 2011, Hepatology.

[7]  W. Lau,et al.  Management of bile duct injury after laparoscopic cholecystectomy: a review , 2010, ANZ journal of surgery.

[8]  Haiyuan Yu,et al.  Detecting overlapping protein complexes in protein-protein interaction networks , 2012, Nature Methods.

[9]  N M Bass,et al.  Fatty‐acid metabolism and the pathogenesis of hepatocellular carcinoma: Review and hypothesis , 1993, Hepatology.

[10]  T. Derrick,et al.  Evaluation of time-series data sets using the Pearson product-moment correlation coefficient. , 1994, Medicine and science in sports and exercise.

[11]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[12]  I. Ng,et al.  Hepatocellular tumors: Immunohistochemical analyses for classification and prognostication , 2011, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[13]  Sandhya Rani,et al.  Human Protein Reference Database—2009 update , 2008, Nucleic Acids Res..

[14]  S. Fan,et al.  Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. , 1994, The New England journal of medicine.

[15]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[16]  W. V. Steenbergen,et al.  αl-Antitrypsin Deficiency: An Overview. , 1993, Acta clinica Belgica.

[17]  M. Miyazaki,et al.  Identification of novel immunohistochemical tumor markers for primary hepatocellular carcinoma; clathrin heavy chain and formiminotransferase cyclodeaminase , 2008, Hepatology.

[18]  M. Kojiro,et al.  Pathology of Hepatocellular Carcinoma , 2006 .

[19]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Jung-Hwan Yoon,et al.  Gene Expression–Based Recurrence Prediction of Hepatitis B Virus–Related Human Hepatocellular Carcinoma , 2008, Clinical Cancer Research.

[21]  Gordon K Smyth,et al.  Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2004, Statistical applications in genetics and molecular biology.

[22]  Akhilesh Pandey,et al.  A quantitative proteomic approach for identification of potential biomarkers in hepatocellular carcinoma. , 2008, Journal of proteome research.

[23]  Kara Dolinski,et al.  The BioGRID Interaction Database: 2011 update , 2010, Nucleic Acids Res..

[24]  K. Ishak,et al.  Combined hepatocellular‐cholangiocarcinoma. A histologic and immunohistochemical study , 1985, Cancer.

[25]  Y. Miyagi,et al.  Activation of cancer cell migration and invasion by ectopic synthesis of coagulation factor VII. , 2006, Cancer research.

[26]  J. Luk,et al.  Association of Mortalin (HSPA9) with Liver Cancer Metastasis and Prediction for Early Tumor Recurrence* , 2008, Molecular & Cellular Proteomics.

[27]  A. Burroughs,et al.  Correction of both prothrombin time and primary haemostasis by recombinant factor VII during therapeutic alcohol injection of hepatocellular cancer in liver cirrhosis. , 1999, Journal of hepatology.